Login
Toggle sidebar

Lint: portal-vein-thrombosis

List Punctuation
error

"iodine quantification may improve characterisation of portal vein thrombi during the late hepatic arterial phase especially in patients with hepatocellular carcinoma 19."

Line 84:179 · Do not put full stops at the end of a list item.

"dual-energy post-processing has potential to significantly increase contrast-to-noise ratio and the sensitivity for the diagnosis of venous thrombosis 20."

Line 85:164 · Do not put full stops at the end of a list item.
Adjectival Hyphens
error

"dual-energy post-processing has potential to significantly increase contrast-to-noise ratio and the sensitivity for the diagnosis of venous thrombosis 20."

Line 85:20 · Only use medical adjectival hyphens where the letters at the end and start of the compound word are the same, e.g. post-transplant. In this case, don't use the hyphen: 'post-processing'.
Words We Never Use
error

"beware slow or turbulent flow artefacts"

Line 94:38 · Radiopaedia always uses 'artifacts' rather than 'artefacts'.

"beware slow flow-related artefacts"

Line 102:33 · Radiopaedia always uses 'artifacts' rather than 'artefacts'.
Isotope Notation
error

"18F-FDG PET-CT has demonstrated a promising ability to differentiate between bland thrombus and malignant (tumour thrombus) portal vein thrombosis 5-11. The optimal imaging protocol appears to be with hybrid imaging part state-of-the-art CT including IV iodinated contrast media 10. Demonstrated features are:"

Line 119:9 · Write the isotope as symbol-mass, e.g. F-18, not '18F'.
Ranges
warning

"The demographics of patients with portal venous thrombosis will match those of the underlying condition. The prevalence of portal vein thrombosis in patients with underlying liver cirrhosis, but without co-incident hepatocellular carcinoma, is between 10-18% with an annual incidence between 4-24% 17,18."

Line 3:262 · Don't add words such as 'from' or 'between' to describe a range of numbers.

"The demographics of patients with portal venous thrombosis will match those of the underlying condition. The prevalence of portal vein thrombosis in patients with underlying liver cirrhosis, but without co-incident hepatocellular carcinoma, is between 10-18% with an annual incidence between 4-24% 17,18."

Line 3:302 · Don't add words such as 'from' or 'between' to describe a range of numbers.
Acronyms
warning

"suggested optimal cutoff value: max SUV 2.3-3.6 8,11"

Line 123:47 · 'SUV' has no definition. Spell it out if it's unfamiliar to the audience.

"management of portal hypertension (beta-blockers, diuretics, and TIPS)"

Line 130:76 · 'TIPS' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Dual energy CT"

Line 82:1 · "Dual energy CT" is not a recognised heading for this article type.

"PET-CT"

Line 118:1 · "PET-CT" should be H3, not H2.